The 2022 Global Forecast for Biosimilars (2023-2028 Outlook), published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market for over 50 countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2019, projections for 2020 to 2022 and forecasts for 2023 to 2028. Product shipments include the total value of all products produced and shipped by all producers. For selected products, this can represent value of receipts, value of production, or value of work done. More than 50 countries are featured in this report as well as global and regional summaries. Product shipments value are presented in US Dollars and local currency units for historical and forecast years. Published annually, this report provides a unique and accurate estimate on market sizing for this equipment/material using a proprietary economic model that integrates historical trends (horizontal analysis) and longitudinal analysis of incorporated industries (vertical analysis). Regional summaries include North America, Europe, Asia-Pacific, Latin America, Africa, and Middle East. Percent shares are presented for each region as a share of the global market. Product shipments values are also broken down by related costs, such as cost of materials, cost of fuels/electricity, contract work and value added, as well as capital expenditures, such as expenditures on buildings, machinery, vehicles and computers. These markets are labeled by Barnes Reports as "emerging market" because their annual growth rate is above seven percent, which is the historical average return of the NYSE stock market. Therefore, any market, industry, investment or growth rate that exceeds the foremost investment market in the world would be considered an above average growth rate. They are also labeled "high tech" markets because they are new, cutting-edge markets are are currently small but are projected to have extraordinary potentials in the next five years. This report does not list key players/companies in the market but focuses on a top-down and outlook view of the market despite the existing and entering of market companies. Barnes Reports' Manufacturing & Markets reports are an essential part of any GAP analysis, benchmarking project, SWOT analysis, business plan, risk analysis, or growth-share matrix.
2022 Global Forecast for Biosimilars (2023-2028 Outlook)